|
|
| Regel 1: |
Regel 1: |
| | + | Hello world |
| | | | |
| − | {{IssueBox|Deze pagina is nog in bewerking}}
| + | =Hello world kopje 1= |
| − | [[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]
| + | balalaalal |
| | | | |
| − | =Addenda voor inhoudelijke gegevens= | + | ==Kopje 2== |
| − | ==Patiënt J. XXX_Amaya==
| + | alaskjdl |
| − | {| class="wikitable" width="85%"
| + | adslkjf kjs dfkjas;ldkfj;ask djf;lkasdj flkasdj fl;kasjd'j |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|J. XXX_Amaya
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911764 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|6 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Man (code = 'M')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|2 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|10 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:00
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 14:32
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Relatie naar afspraak of gebruik: TA
| |
| − | |style="background-color: white;"|MBH_513_2_TA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Opname (code = '305335007')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Furosemide tablet 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 14:32
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Relatie naar afspraak of gebruik: MGB
| |
| − | |style="background-color: white;"|MBH_513_3_MGB_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Opname (code = '305335007')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden van voorschrijven
| |
| − | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Methotrexaat tablet 2,5mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per week 5 stuks
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|29 aug 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Aanvullende informatie
| |
| − | |style="background-color: white;"|Bewust hoge dosering (code = '1')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_4
| |
| − | |}
| |
| − | ===Toedieningsafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 12:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|27 aug 2018, om 14:52
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|29 aug 2018, om 09:45
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Aanvullende informatie
| |
| − | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_4
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|1 sep 2018, om 15:39
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 1 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Furosemide tablet 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_513_2_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 20:40
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 2 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Furosemide tablet 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_513_2_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Informant
| |
| − | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger.
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 21:39
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Furosemide tablet 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_513_2_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Informant
| |
| − | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|16 aug 2018, om 20:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 16 aug 2018, gedurende 1 dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde verstrekking
| |
| − | |style="background-color: white;"|MBH_5132_2_MVE_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_5132_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|31 aug 2018, om 20:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Methotrexaat tablet 2,5mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="3"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per week 5 stuks
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_513_3_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|30 aug 2018, om 22:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_513_4_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_513_4
| |
| − | |}
| |
| − | ==Patiënt Pauline P. XXX_Bourgonje==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|Pauline P. XXX_Bourgonje
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911296 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|1 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Vrouw (code = 'F')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|27 aug 2018, om
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10%
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '53')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Zo nodig 2 maal per dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_123_1
| |
| − | |}
| |
| − | ===Toedieningsafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|27 aug 2018, om 00:00
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '53')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Zo nodig 2 maal per dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_123_1
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|12 aug 2018, om 20:58
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 11 aug 2018, gedurende 2 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10%
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="3"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_123_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_123_1
| |
| − | |}
| |
| − | ==Patiënt J. XXX_Cnossen==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|J. XXX_Cnossen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911740 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|4 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Man (code = 'M')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|26 mei 2018, om 12:11
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Inhalatie (code = '62')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 dosis
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|5 jul 2018, om 13:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Indicatie vervallen (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Inhalatie (code = '62')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 dosis
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|21 apr 2017, om 10:19
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oculair (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|In beide ogen (code = '1026')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 druppel
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|2 sep 2017, om 17:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Indicatie vervallen (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oculair (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|In beide ogen (code = '1026')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 druppel
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|26 mei 2018, om 12:11
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|30 aug 2018, om 13:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Onderbreking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|7 nov 2017, om 14:23
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Omeprazol tablet MSR 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_4
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|24 jan 2018, om 08:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Onderbreking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Omeprazol tablet MSR 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_4
| |
| − | |}
| |
| − | ===Toedieningsafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|26 mei 2018, om 12:11
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Inhalatie (code = '62')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 dosis
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|5 jul 2018, om 13:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Inhalatie (code = '62')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 dosis
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|21 apr 2017, om 10:19
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oculair (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|In beide ogen (code = '1026')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 druppel
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|2 sep 2017, om 17:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oculair (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|In beide ogen (code = '1026')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 druppel
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|26 mei 2018, om 12:30
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|30 aug 2018, om 14:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Onderbreking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|7 nov 2017, om 15:23
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_4
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|24 jan 2018, om 09:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Onderbreking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_4
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|6 jul 2018, om 12:11
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 6 jul 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Inhalatie (code = '62')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 dosis
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|18 jun 2018, om 15:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Inhalatie (code = '62')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 dosis
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_1_MA_2
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 apr 2017, om 10:19
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 apr 2017, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oculair (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|In beide ogen (code = '1026')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 druppel
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_2_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|15 aug 2017, om 17:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oculair (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|In beide ogen (code = '1026')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 druppel
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_2_MA_2
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|8 mei 2018, om 12:11
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 8 mei 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_3_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|12 aug 2017, om 13:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Onderbreking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_3_MA_2
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|20 okt 2017, om 14:23
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 20 okt 2017, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Omeprazol tablet MSR 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_4_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_4
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|6 jan 2018, om 08:54
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Onderbreking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Omeprazol tablet MSR 40mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_313_4_MA_2
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_313_4
| |
| − | |}
| |
| − | ==Patiënt R. XXX_Dirksz==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|R. XXX_Dirksz
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911326 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|1 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Man (code = 'M')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|15 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Metoclopramide zetpil 20mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Rectaal (code = '12')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|4 aug 2018, om 14:55
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Zestril tabel 10mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|4 aug 2018, om 14:57
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_3
| |
| − | |}
| |
| − | ===Toedieningsafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|15 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Rectaal (code = '12')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|4 aug 2018, om 14:55
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Zestril tabel 10mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|4 aug 2018, om 14:57
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ROTER APC TABLET
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_3
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|17 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Metoclopramide zetpil 20mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Rectaal (code = '12')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_113_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|21 aug 2018, om 14:55
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Zestril tabel 10mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_113_2_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|5 aug 2018, om 14:57
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_113_3_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_113_3
| |
| − | |}
| |
| − | ==Patiënt R. XXX_Gobee==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|R. XXX_Gobee
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911314 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|1 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Vrouw (code = 'F')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|15 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|25 jul 2018, om 09:13
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Relatie naar afspraak of gebruik: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|25 jul 2018, om 09:13
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Relatie naar afspraak of gebruik: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_2
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Geen of onvoldoende effect (code = '5')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|19 aug 2018, om 09:13
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Relatie naar afspraak of gebruik: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_3
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|20 aug 2018, om 16:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Relatie naar afspraak of gebruik: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_4
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Wens patiënt (code = '12')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | ===Toedieningsafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|15 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|25 jul 2018, om 09:13
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|25 jul 2018, om 09:13
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|19 aug 2018, om 09:13
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|19 aug 2018, om 16:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|18 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|24 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|30 jul 2018, om 19:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: TA
| |
| − | |style="background-color: white;"|MBH_213_1_TA_3
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|18 aug 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_3
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|24 aug 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_213_1_MA_5
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_213_1
| |
| − | |}
| |
| − | ==Patiënt J. XXX_Kilkenny==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|J. XXX_Kilkenny
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911752 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|5 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Vrouw (code = 'F')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|29 aug 2018, om 15:34
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Stoptype
| |
| − | |style="background-color: white;"|Staking
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_323_1
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|24 aug 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_323_1
| |
| − | |}
| |
| − | ==Patiënt R. XXX_Ruys==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|R. XXX_Ruys
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911351 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|1 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Man (code = 'M')
| |
| − | |}
| |
| − | ==Patiënt R. XXX_Strengersz==
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patient
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Naamgegevens
| |
| − | |style="background-color: white;"|R. XXX_Strengersz
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|999911338 [BSN]
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Patient identificatienummer
| |
| − | |style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geboortedatum
| |
| − | |style="background-color: white;"|1 aug 1964
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geslacht
| |
| − | |style="background-color: white;"|Vrouw (code = 'F')
| |
| − | |}
| |
| − | ===Medicatieafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|15 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 à 2 stuks
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|14 aug 2018, om 10:26
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10%
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_4
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|14 aug 2018, om 10:46
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Ibuprofen PCH tablet 600mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 0.25 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_5
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Waterstofperoxide 30MG/ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="6"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Niet van toepassing (code = '1')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Eerst oplossen in water (code = '27')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 10 à 15 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_6
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_7
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="6"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Voor de nacht (code = '1128')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Op maandag, woensdag en vrijdag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_8
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_9
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon)
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_10
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Fusidinezuur creme 20mg/g
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="7"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Dun aanbrengen (code = '1033')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 1
| |
| − | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 2
| |
| − | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 3
| |
| − | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_11
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT)
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_12
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|6 aug 2018, om 09:12
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|0.5 ml per uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_13
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|14 aug 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|0.2 à 0.5 ml per uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_13
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T)
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Transdermaal (code = '58')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_14
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatieafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Reden afspraak
| |
| − | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Overig
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 10 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_15
| |
| − | |}
| |
| − | ===Toedieningsafspraken===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|15 jul 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 à 2 stuks
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|14 aug 2018, om 10:26
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_4
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|14 aug 2018, om 10:46
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Ibuprofen PCH tablet 600mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 0.25 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_5
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="6"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Niet van toepassing (code = '1')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Eerst oplossen in water (code = '27')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 10 à 15 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_6
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_7
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="6"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Voor de nacht (code = '1128')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Op maandag, woensdag en vrijdag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_8
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|INEGY TABLET 10/20MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_9
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|MARVELON TABLET
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_10
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|FUCIDIN CREME 20MG/G
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="7"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Dun aanbrengen (code = '1033')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 1
| |
| − | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 2
| |
| − | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 3
| |
| − | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_11
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_12
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|6 aug 2018, om 09:12
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|0.5 ml per uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_13
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|14 aug 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|0.2 à 0.5 ml per uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_13
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 11:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 16 aug 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Transdermaal (code = '58')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_14
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Toedieningsafspraak
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Afspraakdatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Verstrekker
| |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Overig
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 10 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_15
| |
| − | |}
| |
| − | ===Medicatiegebruik===
| |
| − |
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 16:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_1_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_1
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 14:25
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_2_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_2
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 10:45
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag 1 à 2 stuks
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_3_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_3
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|19 aug 2018, om 13:44
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10%
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Cutaan (code = '7')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|3 maal per dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_4_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_4
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 12:38
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Ibuprofen PCH tablet 600mg
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 0.25 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_5_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_5
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 21:37
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Waterstofperoxide 30MG/ML
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="6"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Niet van toepassing (code = '1')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Eerst oplossen in water (code = '27')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 10 à 15 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_6_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_6
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 14:05
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Elke dag om 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_7_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_7
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 20:10
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Subcutaan (code = '21')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Elke dag om 16 internationale eenheid
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_7_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_7
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 23:59
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="5"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Voor de nacht (code = '1128')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Aanbrengen (code = '1018')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Op maandag, woensdag en vrijdag
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_8_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_8
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 22:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_9_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_9
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 09:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon)
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="3"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_10_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_10
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 15:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Fusidinezuur creme 20mg/g
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="6"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Aanvullende instructie
| |
| − | |style="background-color: white;"|Dun aanbrengen (code = '1033')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie 1
| |
| − | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_11_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_11
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 22:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT)
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Oraal (code = '9')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_12_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_12
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 22:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Tot nader order
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T)
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister).
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Transdermaal (code = '58')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_14_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_14
| |
| − | |}
| |
| − | {| class="wikitable" width="85%"
| |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Medicatie gebruik
| |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| − | |colspan="2" width="25%"| Gegevenselement
| |
| − | || Waarde
| |
| − | | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Registratiedatum
| |
| − | |style="background-color: white;"|3 sep 2018, om 10:35
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gebruiksperiode
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Voorschrijver
| |
| − | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Geneesmiddel
| |
| − | |style="background-color: white;"|Overig
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="3"|Gebruiksinstructie
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |rowspan="4"|
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Omschrijving
| |
| − | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Toedieningsweg
| |
| − | |style="background-color: white;"|Parenteraal (code = '10')
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | ||Doseerinstructie
| |
| − | |style="background-color: white;"|2 maal per dag 10 ml
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Gerelateerde afspraak: MA
| |
| − | |style="background-color: white;"|MBH_413_15_MA_1
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|Auteur
| |
| − | |style="background-color: white;"|Patiënt
| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| − | |colspan="2"|MBH identificatie
| |
| − | |style="background-color: white;"|MBH_413_15
| |
| − | |}
| |
